April 2, 2020
Austrian Aperion OKd to phase2 test APN01 to treat COVID-19 in 3 EU countries
Apeiron Biologics AG has received regulatory approvals in Austria, Germany and Denmark to kickoff a Phase II clinical trial of APN01 to treat COVID-19.